NeueHealth (NYSE:NEUE) reported quarterly losses of $(1.80) per share which beat the analyst consensus estimate of $(4.18) by 56.94 percent. This is a 22.08 percent increase over losses of $(2.31) per share from the same period last year. The company reported quarterly sales of $215.79 million which missed the analyst consensus estimate of $316.00 million by 31.71 percent. This is a 11.96 percent decrease over sales of $245.09 million the same period last year.